We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$589M
AUM Growth
+$142M
Cap. Flow
+$127M
Cap. Flow %
21.51%
Top 10 Hldgs %
17.61%
Holding
642
New
226
Increased
94
Reduced
75
Closed
242

Top Buys

Rank Stock Value
1
CONE
CyrusOne Inc Common Stock
CONE
+$15.2M
2
AMZN icon
Amazon
AMZN
+$12.7M
3
DELL icon
Dell
DELL
+$11.8M
4
TAP icon
Molson Coors Class B
TAP
+$9.99M
5
IRT icon
Independence Realty Trust
IRT
+$9.32M

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$12.7M
2
UNIT
Uniti Group
UNIT
+$7.55M
3
FTNT icon
Fortinet
FTNT
+$7.54M
4
TT icon
Trane Technologies
TT
+$5.9M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$5.46M

Sector Composition

Rank Sector Weight
1 Technology 19.65%
2 Consumer Discretionary 17.38%
3 Healthcare 11.58%
4 Communication Services 9.88%
5 Financials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDC
376
DELISTED
First Data Corporation
FDC
$181K 0.03%
+13,787
New +$178K
DVAX
377
DELISTED
Dynavax Technologies
DVAX
$179K 0.03%
+17,070
New +$245K
VIRT icon
378
Virtu Financial
VIRT
$5.13B
$167K 0.03%
+11,180
New +$188K
SC
379
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$164K 0.03%
13,472
-1,660
-11% -$19.2K
NE
380
DELISTED
Noble Corporation
NE
$164K 0.03%
25,933
-14,030
-35% -$94.3K
ARIA
381
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$156K 0.03%
+11,365
New +$114K
EGO icon
382
Eldorado Gold
EGO
$7.91B
$152K 0.03%
+7,715
New +$159K
OCUL icon
383
Ocular Therapeutix
OCUL
$1.8B
$143K 0.02%
20,903
+1,233
+6% +$7.52K
TRHC
384
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$143K 0.02%
+10,000
New +$146K
AGTC
385
DELISTED
Applied Genetic Technologies Corporation
AGTC
$140K 0.02%
+14,335
New +$193K
FCH
386
DELISTED
Felcor Lodging Trust
FCH
$135K 0.02%
21,028
-36,437
-63% -$237K
CRBP icon
387
Corbus Pharmaceuticals
CRBP
$165M
$133K 0.02%
+649
New +$80.7K
ZGNX
388
DELISTED
Zogenix, Inc.
ZGNX
$130K 0.02%
+11,406
New +$105K
AGEN
389
Agenus
AGEN
$310M
$128K 0.02%
+909
New +$104K
ATXS
390
DELISTED
Astria Therapeutics
ATXS
$123K 0.02%
+333
New +$87.7K
ZNGA
391
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$115K 0.02%
+39,395
New +$110K
ESV
392
DELISTED
Ensco Rowan plc
ESV
$111K 0.02%
+3,254
New +$111K
PGNX
393
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$97K 0.02%
+15,374
New +$92.9K
VIAV icon
394
Viavi Solutions
VIAV
$9.01B
$91K 0.02%
+12,407
New +$90.9K
ALJ
395
DELISTED
Alon USA Energy Inc
ALJ
$90K 0.02%
11,152
-9,094
-45% -$67.5K
AVP
396
DELISTED
Avon Products, Inc.
AVP
$79K 0.01%
13,961
-30,939
-69% -$154K
TPST icon
397
Tempest Therapeutics
TPST
$13.7M
$72K 0.01%
3
– –
IMMU
398
DELISTED
Immunomedics Inc
IMMU
$67K 0.01%
20,590
-32,422
-61% -$90.7K
HOS
399
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$61K 0.01%
+11,034
New +$71.8K
AAL icon
400
American Airlines Group
AAL
$10.1B
– –
-96,210
Closed -$2.72M
14 15
16
17 18

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Schonfeld Strategic Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Schonfeld Strategic Advisors held 642 positions worth $589M, up 32% from $447M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Schonfeld Strategic Advisors deployed $127M of net new capital in Q3 2016, opening 226 new positions and adding to 94 existing holdings. Its largest new stake was CyrusOne Inc Common Stock: 294,137 shares worth $14M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Uniti Group, an estimated $7.55M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2016 buy was CyrusOne Inc Common Stock: 294,137 shares worth $14M.
  • Schonfeld Strategic Advisors added most to Amazon in Q3 2016, an estimated $12.7M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2016 reduction was Uniti Group, cutting an estimated $7.55M.
  • Schonfeld Strategic Advisors fully exited Charter Communications in Q3 2016, selling an estimated $12.7M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 18% of its $589M portfolio in Q3 2016.
  • Schonfeld Strategic Advisors opened 226 new positions and closed 242 in Q3 2016.
  • Schonfeld Strategic Advisors's portfolio value rose 32% quarter-over-quarter to $589M.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.